Safety studies must consider cost

Stephen Thornton's acerbic response in HSJ in September to my concerns about the patient safety industry engenders even greater concerns about this policy area, writes Alan Maynard

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here